TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Instil Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$5.79−0.12 (-2.03%)
Close on Oct 19, 2026
- Market cap
- $39.27M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$13.30 (−69.66%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $39.27M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.37
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$30.28M
- EPS, diluted
- -$4.47
- Book value per share
- $15.83
- Diluted shares
- 7M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
–
Operating income
-$37.17M
Net income
-$30.28M
EPS, diluted
-$4.47
Free cash flow
–
Reported periodTrailing twelve months